Browse Items (8 total)
- Tags: Neoplasm Recurrence
Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer.
Tags: 2005, Adult, Aged, Akram T, American Journal of Obstetrics & Gynecology, Antineoplastic Agents, Carboplatin – Administration and Dosage, Combined, Drug Administration Schedule, Drug Toxicity, Endometrial Neoplasms – Drug Therapy, Fanning J, Human, Kaplan-Meier Estimator, Local – Drug Therapy, Maseelall P, Middle Age, Neoplasm Recurrence, Paclitaxel – Administration and Dosage, Retrospective Design, Severity of Illness, Survival
Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer.
Tags: 2005, Adult, Aged, Akram Tahira, American journal of obstetrics and gynecology, Antineoplastic Agents, Antineoplastic Agents/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use, Carboplatin/administration & dosage, Drug Administration Schedule, Endometrial Neoplasms/*drug therapy, Fanning James, Female, Humans, Local/drug therapy, Maseelall Priya, Middle Aged, Neoplasm Recurrence, Paclitaxel/administration & dosage, Phytogenic/administration & dosage, Survival Analysis, Treatment Outcome
Phase II study of gefitinib in patients with advanced salivary gland cancers.
Tags: 2015, 80 and over, Adenocarcinoma/drug therapy/mortality/pathology, adenoid cystic carcinoma, Adenoid Cystic/*drug therapy/mortality/pathology, Adult, Aged, Antineoplastic Agents/*therapeutic use, Blumenschein George R Jr, Carcinoma, Department of Internal Medicine, Disease-Free Survival, Dose-Response Relationship, Drug, Drug Administration Schedule, El-Naggar Adel K, Female, Gefitinib, Glisson Bonnie S, Gonzalez-Angulo Ana M, Head & neck, Humans, Jakob John A, Kies Merrill S, Kupferman Michael E, Lee J Jack, Liu Diane D, Local/*drug therapy/mortality/pathology, Male, Maximum Tolerated Dose, Middle Aged, NEOMED College of Medicine, Neoplasm Invasiveness/pathology, Neoplasm Recurrence, Neoplasm Staging, non-adenoid cystic carcinoma, Prognosis, Quinazolines/*therapeutic use, Remission Induction, response to therapy, salivary gland cancer, Salivary Gland Neoplasms/*drug therapy/mortality/pathology, Survival Analysis, Treatment Outcome
Generation of "virtual" control groups for single arm prostate cancer adjuvant trials.
Tags: *Nomograms, *Prostatectomy, 2014, Adjuvant/*methods, Aged, Ahlering Thomas, Antineoplastic Agents/therapeutic use, Carpenter Philip M, Chemotherapy, Chen Xin, Control Groups, Controlled Clinical Trials as Topic, Deng Mingsen, Disease-Free Survival, Gurley Michael J, Humans, Jia Zhenyu, Jiang Jun, Kattan Michael W, Koziol James A, Lee Chung, Lilly Michael B, Local/*drug therapy/mortality/pathology/surgery, Male, McClelland Michael, McLaren Christine E, Mercola Dan, Middle Aged, Neoplasm Recurrence, Pan Cong, PloS one, Prostate/drug effects/pathology/surgery, Prostatic Neoplasms/*drug therapy/mortality/pathology/surgery, Ruckle Herbert, Sawyers Anne, Skarecky Douglas, Sutton Manuel, Treatment Outcome, Wang Yipeng, Wang-Rodriguez Jessica, Xia Xiao-Qin, Zhu Jian-Guo
Facilitating breast-conserving surgery and preventing recurrence: aromatase inhibitors in the neoadjuvant and adjuvant settings.
Tags: *Mastectomy, 2008, Adjuvant, Annals of surgical oncology, Antineoplastic Agents/*administration & dosage, Aromatase Inhibitors/*administration & dosage, Breast Neoplasms/*drug therapy/*surgery, Chemotherapy, Female, Humans, Local/*prevention & control, Mamounas Eleftherios P, Neoadjuvant Therapy, Neoplasm Recurrence, Segmental
Ipsilateral breast tumor recurrence after lumpectomy: is it time to take the bull by the horns?
Tags: 2001, Adult, Breast Neoplasms – Pathology, Breast Neoplasms – Surgery, Breast Neoplasms – Therapy, Combined Modality Therapy, Female, Journal of Clinical Oncology, Local – Pathology, Local – Surgery, Local – Therapy, Lumpectomy, Mamounas E P, Mamounas Eleftherios P, Neoadjuvant Therapy, Neoplasm Metastasis, Neoplasm Recurrence, Prognosis
The Role of MRI in the Follow-up of Women Undergoing Breast-conserving Therapy.
Tags: *Magnetic Resonance Imaging, 2016, Aftercare, Ahlawat Stuti, American journal of clinical oncology, Breast Neoplasms/*diagnostic imaging/*surgery, Female, Humans, Khan Atif, Local/*diagnostic imaging, Mammography, Mastectomy, Neoplasm Recurrence, Population Surveillance/*methods, Segmental, Shah Chirag, Shah Shilpi S, Tendulkar Rahul D, Vicini Frank, Wazer David E
Selective lateral compartment neck dissection for thyroid cancer.
Tags: 2013, 80 and over, Adenocarcinoma, Adult, Aged, Carcinoma, Female, Follicular/mortality/secondary/surgery, Follow-Up Studies, Humans, Local/mortality/pathology/surgery, Lymph Node Excision/*methods, Lymph Nodes/anatomy & histology/surgery, Lymphatic Metastasis, Male, McHenry Christopher R, Medullary/mortality/secondary/*surgery, Middle Aged, Morbidity, Neck Dissection/*methods, Neck Muscles/anatomy & histology/surgery, Neoplasm Recurrence, Papillary/mortality/secondary/surgery, Retrospective Studies, Selective lateral compartment neck dissection, The Journal of surgical research, Thyroid cancer, Thyroid Neoplasms/mortality/pathology/*surgery, Thyroidectomy/*methods, Welch Kellen, Young Adult